1. Home
  2. COEP vs OPAD Comparison

COEP vs OPAD Comparison

Compare COEP & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • OPAD
  • Stock Information
  • Founded
  • COEP 2017
  • OPAD 2015
  • Country
  • COEP United States
  • OPAD United States
  • Employees
  • COEP N/A
  • OPAD N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • OPAD Real Estate
  • Sector
  • COEP Health Care
  • OPAD Finance
  • Exchange
  • COEP Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • COEP 27.4M
  • OPAD 25.3M
  • IPO Year
  • COEP N/A
  • OPAD N/A
  • Fundamental
  • Price
  • COEP $10.82
  • OPAD $1.44
  • Analyst Decision
  • COEP
  • OPAD Hold
  • Analyst Count
  • COEP 0
  • OPAD 5
  • Target Price
  • COEP N/A
  • OPAD $2.38
  • AVG Volume (30 Days)
  • COEP 56.9K
  • OPAD 2.2M
  • Earning Date
  • COEP 08-15-2025
  • OPAD 08-04-2025
  • Dividend Yield
  • COEP N/A
  • OPAD N/A
  • EPS Growth
  • COEP N/A
  • OPAD N/A
  • EPS
  • COEP N/A
  • OPAD N/A
  • Revenue
  • COEP $62,874.00
  • OPAD $794,159,000.00
  • Revenue This Year
  • COEP N/A
  • OPAD N/A
  • Revenue Next Year
  • COEP N/A
  • OPAD $40.79
  • P/E Ratio
  • COEP N/A
  • OPAD N/A
  • Revenue Growth
  • COEP N/A
  • OPAD N/A
  • 52 Week Low
  • COEP $2.31
  • OPAD $0.91
  • 52 Week High
  • COEP $13.70
  • OPAD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • OPAD 44.75
  • Support Level
  • COEP $11.30
  • OPAD $1.35
  • Resistance Level
  • COEP $12.71
  • OPAD $4.95
  • Average True Range (ATR)
  • COEP 0.89
  • OPAD 0.71
  • MACD
  • COEP 0.18
  • OPAD -0.10
  • Stochastic Oscillator
  • COEP 54.39
  • OPAD 2.20

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: